Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-001736
Filing Date
2015-05-15
Accepted
2015-05-15 08:09:47
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbvx10q_mar312015.htm 10-Q 871278
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER REQUIRED BY SECTION 302 OF THE SARB ex31-1.htm EX-31.1 12185
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER REQUIRED BY SECTION 302 OF THE SARB ex31-2.htm EX-31.2 12273
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO ex32.htm EX-32 11278
  Complete submission text file 0001415889-15-001736.txt   3126842

Data Files

Seq Description Document Type Size
5 mbvx-20150331.xml EX-101.INS 264350
6 mbvx-20150331.xsd EX-101.SCH 28662
7 mbvx-20150331_cal.xml EX-101.CAL 35295
8 mbvx-20150331_def.xml EX-101.DEF 99275
9 mbvx-20150331_lab.xml EX-101.LAB 203119
10 mbvx-20150331_pre.xml EX-101.PRE 152982
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31265 | Film No.: 15865563
SIC: 2834 Pharmaceutical Preparations